Log In
BCIQ
Print this Print this
 

ozanimod (RPC1063)

  Manage Alerts
Collapse Summary General Information
Company Celgene Corp.
DescriptionSelective sphingosine 1-phosphate receptor 1 (S1PR1; S1P1; EDG1) and S1PR5 modulator
Molecular Target Sphingosine 1-phosphate receptor 1 (S1PR1) (S1P1) (EDG1) ; Sphingosine 1-phosphate receptor 5 (S1PR5) (EDG8) (S1P5)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$7,321.0M

$7,321.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

08/27/2015

$7,321.0M

$7,321.0M

0

Get a free BioCentury trial today